Results 131 to 140 of about 962,797 (324)
Leaf anatomy of species of Calea sect. Lemmatium (Asteraceae) with a taxonomic emphasis
Nordic Journal of Botany, EarlyView.Calea sect. Lemmatium is one of five sections of Calea (Neurolaeneae, Asteraceae), containing 12 species that are morphologically similar, which makes their identification difficult to non‐experts. The current study aimed to provide an anatomical characterization of species from Calea sect.
Maria José de Sousa Monteiro +3 more
wiley +1 more source
Phytochemical Analysis, EarlyView.Abstract Introduction Osteoporosis, one of the common bone diseases, manifests itself as a decrease in bone mass. Recently, the use of medicinal plants in the search for effective and low‐toxicity therapeutics for the prevention or treatment of osteoporosis has become a trending topic.
Sibel Kaymak +6 more
wiley +1 more source
Call for Standardizing Uncaria rhynchophylla as the Sole Origin of Uncariae Ramulus cum Uncis
Phytochemical Analysis, EarlyView.ABSTRACT Background Uncariae Ramulus cum Uncis (URCU) is a widely used traditional Chinese medicine (TCM) for treating neurodegenerative disorders. The Chinese Pharmacopeia recognizes five Uncaria species as authorized botanical sources of URCU; however, there is currently no established quality control method for individual species.
Hau‐Yee Fung +5 more
wiley +1 more source
Polymer International, EarlyView.An overview and categorization of man‐made per‐ or polyfluoroalkyl substances (PFASs) including low‐molar‐mass and high‐molar‐mass fluorochemicals, and their international regulations is presented. Though certain PFASs are toxic, bioaccumulative and cross the human cellular membranes, others, such as fluoropolymers, are safe, reliable and involved in ...
Bruno Améduri
wiley +1 more source
State‐of‐the‐Art on Model‐Informed Drug Development Approaches for Pediatric Rare Diseases
CPT: Pharmacometrics &Systems Pharmacology, EarlyView.ABSTRACT Pediatric rare diseases present unique challenges for drug development due to small patient populations, ethical constraints on clinical trial design, and limited prospectively defined natural history data. Model‐Informed Drug Development (MIDD) has emerged as a powerful paradigm to address these challenges by leveraging quantitative methods ...
Rajesh Krishna +4 more
wiley +1 more source
Calcium oxalate nephrolithiasis: Defective oxalate transport
Kidney International, 1991 A. Borsatti +19 more
openaire +6 more sources
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
Small, EarlyView.The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa +4 more
wiley +1 more source
On the Study of the Coseparation of Thorium. (UXI) with Calcium Oxalate [PDF]
, 1964 B. C. Purkayastha, Souvik Bhattacharyya
openalex +1 more source
Small, EarlyView.Dual‐salt electrolytes with low fluorine content high voltage sodium‐ion batteries cathodes: In this work, novel electrolytes containing two low fluorine content salts with enhanced safety features and the ability to passivate the Al current collector is reported. The suitability of these electrolytes in combination with P2‐Na2/3Al1/9Fe1/9Mn2/3Ni1/9O2 (
Yiyue Lu +9 more
wiley +1 more source